An immunohistochemistry study on ZEB2 expression in 116 RCC patients demonstrated high ZEB2 expression in RCC tumours that correlated with poor overall survival (OS) and progression-free survival (PFS) in RCC patients [26]. The gene discussed is ZEB2; the disease is renal cell carcinoma.